secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2026-04-16T23:59:59+00:00
Accession:  0001193125-26-159060
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo appoints William J. Febbo to Board, effective April 14, 2026
------------------------------------------------------------------

- Febbo, 57, is CEO of Performance Health Systems and former CEO of OptimizeRx (OPRX), where he grew revenue from $5M to $92M.
- He received 45,000 RSUs vesting on first anniversary, plus $60K annual cash retainer and $85K annual RSU retainer.
- Appointment expands Board to six directors; Febbo serves as Class II director until 2028 annual meeting.
- Chairman Paul Gudonis cited Febbo's expertise in scaling direct-to-patient healthcare and capital markets credibility.
- Febbo co-founded Merriman Holdings and Digital Capital Network; also MIT linQ faculty and Harvard Business School mentor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000119312526159060/0001193125-26-159060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000119312526159060/myo-20260414.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-159060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer